Which emerging direction includes developing new pharmacotherapies that specifically target craving?

Which emerging direction includes developing new pharmacotherapies that specifically target craving?

• A. Personalized Medicine With Genetics And Biomarkers
• B. Digital Health Interventions
• C. New Pharmacotherapies Targeting Craving
• D. Integrated Care Models

Answer: (C)

Targeting craving with new medications focuses on creating drugs whose primary goal is to reduce the urge to use substances. Craving drives relapse, so medications that blunt this urge can help people stay abstinent and improve long-term outcomes. This direction is distinct from other emerging approaches: personalized medicine with genetics and biomarkers uses individual biological signals to tailor treatments; digital health interventions rely on apps and remote tools to support care; integrated care models emphasize coordinating medical, behavioral, and social services. In craving-targeted pharmacotherapy, the emphasis is on developing agents that modulate brain systems underlying craving—such as stress and reward pathways—to lessen the urge to use, even when triggers are present.

Targeting craving with new medications focuses on creating drugs whose primary goal is to reduce the urge to use substances. Craving drives relapse, so medications that blunt this urge can help people stay abstinent and improve long-term outcomes. This direction is distinct from other emerging approaches: personalized medicine with genetics and biomarkers uses individual biological signals to tailor treatments; digital health interventions rely on apps and remote tools to support care; integrated care models emphasize coordinating medical, behavioral, and social services. In craving-targeted pharmacotherapy, the emphasis is on developing agents that modulate brain systems underlying craving—such as stress and reward pathways—to lessen the urge to use, even when triggers are present.